Dysmenorrhea Treatment Market Research Report With Major Players- Novartis Pharmaceuticals Corporation, Bayer Schering Pharma AG

Dysmenorrhea Treatment: Market Overview
Globally, more than 50% of post pubescent menstruating women are affected by dysmenorrhea, with 10–12% of them having severe dysmenorrhea with incapacitation for 1–3 days each month. Because young women constitute a significant percentage of the adult work force in the US, nearby 600 million working hours or 2 billion dollars are lost annually because of incapacitating dysmenorrhea if adequate relief is not provided. Women who continue to work or to attend classes have been shown to have lower work output or scores during their dysmenorrhea.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/727

It is for the most part ordered into two general classes:
Primary Dysmenorrhea alludes: to menstrual pain without any fundamental pelvic pathology.
Secondary Dysmenorrhea alludes: to menstrual pain connected with a predefined organic etiology.
Symptoms of Dysmenorrhea include cramping pain in the midline in the suprapubic area, and may have associated backache, leg pains, nausea, vomiting, light-headedness and headache.
Global Dysmenorrhea Treatment Market Major Players:
Some of the major players of Global Dysmenorrhea Treatment Market are as follows: Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Alvogen, Pfizer, Inc., Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc., and others.
Global Dysmenorrhea Treatment: Market Growth Influencer
Rising prevalence of dysmenorrhea, high consciousness level and growing concern about dysmenorrhea among females, contribution of companies for developing advanced treatments, and government campaigns with respect to women healthcare are effectively sanctioning the growth of dysmenorrhea treatment market.
However, consequence and complications of long term treatment, extensive morbidity of dysmenorrhea which leads to inadequate treatment, and traditional values of families would hinder the growth of dysmenorrhea treatment market.

Browse Report Details @ https://www.marketresearchfuture.com/reports/dysmenorrhea-treatment-
market

Global Dysmenorrhea Treatment: Market Segmentation
Global Dysmenorrhea Treatment Market by Types:
• Primary and
• Secondary
Global Dysmenorrhea Treatment Market by Treatment methods:
• General Diagnosis
• Non-hormonal medical treatment
• Surgical Treatment
Global Dysmenorrhea Treatment Market by Applications:
• Pharmaceuticals
• Hospitals
• Clinics
• Others
Latest Trends in Dysmenorrhea Treatment Market:
• Novartis receives three FDA Breakthrough Therapy Designations in 2016 for Ilaris to treat rare types of Periodic Fever Syndromes.
• Transcutaneous electrical nerve stimulation (TENS) is an established method for pain relief in Dysmenorrhea, which does not involve the use of medication.

Request Table of Contents for this Report @ https://www.marketresearchfuture.com/request-toc/727

Global Dysmenorrhea Treatment Market Regional Analysis:
The regional analysis includes North America, Europe, Asia Pacific, Middle East and rest of the world.
The Global Dysmenorrhea Treatment Market is expected to grow with a CAGR of more than 3% during the forecasted period due to high usage of low price OTC (over-the-counter) and off-label treatment.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.